|
US1117936A
(en)
*
|
1914-03-04 |
1914-11-17 |
Harry H West |
Circular-knitting machine.
|
|
GB967177A
(en)
|
1959-10-13 |
1964-08-19 |
Rohm & Haas |
A method for preparing pyrrolidinones and piperidinones
|
|
FR1335705A
(fr)
|
1961-10-11 |
1963-08-23 |
Dow Corning |
Silanes cycliques contenant de l'azote, leur préparation et leur hydrolyse
|
|
EP0194599A3
(en)
|
1985-03-14 |
1988-01-20 |
Nissan Chemical Industries Ltd. |
Benzamide derivatives, process for producing the same, and soil fungicides containing the same
|
|
CA2079343A1
(en)
|
1990-03-30 |
1991-10-01 |
Eric E. Allen |
Substituted pyrazoles, isoxazoles and isothiazoles
|
|
GB9122590D0
(en)
|
1991-10-24 |
1991-12-04 |
Lilly Industries Ltd |
Pharmaceutical compounds
|
|
DE4410453A1
(de)
|
1994-03-25 |
1995-09-28 |
Hoechst Ag |
Substituierte heterocyclische Carbonsäureamidester, ihre Herstellung und ihre Verwendung als Arzneimittel
|
|
GB9514160D0
(en)
|
1994-07-25 |
1995-09-13 |
Zeneca Ltd |
Aromatic compounds
|
|
WO1996022022A1
(en)
|
1995-01-19 |
1996-07-25 |
Novartis Ag |
Herbicidal composition
|
|
WO1997018712A1
(en)
|
1995-11-23 |
1997-05-29 |
Novartis Ag |
Herbicidal composition
|
|
CA2238875C
(en)
|
1995-12-15 |
2003-09-16 |
Merck Frosst Canada Inc. |
Tri-aryl ethane derivatives as pde iv inhibitors
|
|
EP0922028A1
(en)
|
1996-08-26 |
1999-06-16 |
Genetics Institute, Inc. |
Inhibitors of phospholipase enzymes
|
|
JPH10114654A
(ja)
|
1996-10-09 |
1998-05-06 |
Fujisawa Pharmaceut Co Ltd |
新規用途
|
|
WO1998031226A1
(de)
|
1997-01-15 |
1998-07-23 |
Novartis Ag |
Herbizides mittel
|
|
GB9716657D0
(en)
|
1997-08-07 |
1997-10-15 |
Zeneca Ltd |
Chemical compounds
|
|
DE19742951A1
(de)
|
1997-09-29 |
1999-04-15 |
Hoechst Schering Agrevo Gmbh |
Acylsulfamoylbenzoesäureamide, diese enthaltende nutzpflanzenschützende Mittel und Verfahren zu ihrer Herstellung
|
|
DE19802697A1
(de)
|
1998-01-24 |
1999-07-29 |
Bayer Ag |
Selektive Herbizide auf Basis von N-Aryl-triazolin(thi)onen und N-Arylsulfonylamino(thio)carbonyltriazolin(thi)onen
|
|
WO1999041238A1
(en)
|
1998-02-13 |
1999-08-19 |
Kureha Kagaku Kogyo K.K. |
N-(phenylsulfonyl) picolinamide derivatives, process for producing the same, and herbicide
|
|
BR9909440A
(pt)
|
1998-04-06 |
2000-12-26 |
Fujisawa Pharmaceutical Co |
Derivados de indol
|
|
DE60012742T2
(de)
|
1999-06-10 |
2005-01-13 |
Warner-Lambert Co. Llc |
Inhibition von amyloid protein aggregation und bilderzeugung von amyloidniederschlägen mit isoindolderivate
|
|
DE19936438A1
(de)
|
1999-08-03 |
2001-02-08 |
Aventis Cropscience Gmbh |
Kombinationen von Herbiziden und Safenern
|
|
DE19940860A1
(de)
|
1999-08-27 |
2001-03-01 |
Bayer Ag |
Selektive Herbizide auf Basis eines substituierten Phenylsulfonyl aminocarbonyltriazolinons und Safenern II
|
|
DE19958381A1
(de)
|
1999-12-03 |
2001-06-07 |
Bayer Ag |
Herbizide auf Basis von N-Aryl-uracilen
|
|
WO2002015902A1
(en)
|
2000-08-23 |
2002-02-28 |
Merck & Co., Inc. |
Method of treating or preventing urinary incontinence using prostanoid ep1 receptor antagonists
|
|
US20020055631A1
(en)
|
2000-09-20 |
2002-05-09 |
Augeri David J. |
N-acylsulfonamide apoptosis promoters
|
|
US6720338B2
(en)
|
2000-09-20 |
2004-04-13 |
Abbott Laboratories |
N-acylsulfonamide apoptosis promoters
|
|
UY26942A1
(es)
|
2000-09-20 |
2002-04-26 |
Abbott Lab |
N-acilsulfonamidas promotoras de la apoptosis
|
|
PL366068A1
(en)
|
2000-10-10 |
2005-01-24 |
Smithkline Beecham Corporation |
Substituted indoles, pharmaceutical compositions containing such indoles and their use as ppar-gamma binding agents
|
|
DE10119721A1
(de)
|
2001-04-21 |
2002-10-31 |
Bayer Cropscience Gmbh |
Herbizide Mittel enthaltend Benzoylcyclohexandione und Safener
|
|
CA2449150C
(en)
|
2001-05-31 |
2011-07-12 |
Vicore Pharma Ab |
Tricyclic compounds useful as angiotensin ii agonists
|
|
SK287806B6
(sk)
|
2001-06-28 |
2011-10-04 |
Pfizer Products Inc. |
Triamid-substituované indoly, benzofurány a benzotiofény ako inhibítory mikrozómového proteínu prenášajúceho triglyceridu (MTP) a/alebo sekrécie apolipoproteínu B (Apo B)
|
|
DE10145019A1
(de)
|
2001-09-13 |
2003-04-03 |
Bayer Cropscience Gmbh |
Kombinationen aus Herbiziden und Safenern
|
|
DE10146873A1
(de)
|
2001-09-24 |
2003-04-17 |
Bayer Cropscience Gmbh |
Heterocyclische Amide und -Iminderivate, Verfahren zu ihrer Herstellung, sie enthaltende Mittel und ihre Verwendung als Schädlingsbekämpfungsmittel
|
|
MXPA04004657A
(es)
|
2001-11-14 |
2004-08-13 |
Teva Pharma |
Formas amorfas y cristalinas de potasio de losartan y proceso para su preparacion.
|
|
JPWO2003043655A1
(ja)
|
2001-11-19 |
2005-03-10 |
小野薬品工業株式会社 |
頻尿の治療剤
|
|
DE10157545A1
(de)
|
2001-11-23 |
2003-06-12 |
Bayer Cropscience Gmbh |
Herbizide Mittel enthaltend Benzoylpyrazole und Safener
|
|
US7247748B2
(en)
|
2002-03-27 |
2007-07-24 |
Smithkline Corporation |
Amide compounds and methods of using the same
|
|
GB0212785D0
(en)
|
2002-05-31 |
2002-07-10 |
Glaxo Group Ltd |
Compounds
|
|
DE60304862T2
(de)
|
2002-06-08 |
2006-11-23 |
Bayer Cropscience Gmbh |
Kombinationen von herbiziden aromatischen carbonsäuren und safener-mitteln
|
|
DE10237461A1
(de)
|
2002-08-16 |
2004-02-26 |
Bayer Cropscience Gmbh |
Herbizide Mittel enthaltend Benzoylpyrazole und Safener
|
|
US20060019932A1
(en)
|
2002-09-06 |
2006-01-26 |
Mancini Joseph A |
Treatment of rheumatoid arthritis by inhibition of pde4
|
|
BR0314943A
(pt)
|
2002-09-30 |
2005-08-02 |
Univ California |
Inibidores da proteìna reguladora da condutância transmembrana da fibrose cìstica e usos destes
|
|
WO2004037798A1
(en)
|
2002-10-22 |
2004-05-06 |
Merck Frosst Canada & Co. |
Nitric oxide releasing selective cyclooxygenase-2 inhibitors
|
|
GB0225548D0
(en)
|
2002-11-01 |
2002-12-11 |
Glaxo Group Ltd |
Compounds
|
|
WO2004046141A1
(en)
|
2002-11-21 |
2004-06-03 |
Vicore Pharma Ab |
New tricyclic angiotensin ii agonists
|
|
WO2004056775A1
(en)
|
2002-12-20 |
2004-07-08 |
Pfizer Products Inc. |
Microsomal triglyceride transfer protein inhibitors
|
|
EP1578725A1
(en)
|
2002-12-20 |
2005-09-28 |
Pfizer Products Inc. |
Microsomal triglyceride transfer protein inhibitors
|
|
EP1603884A4
(en)
|
2003-02-28 |
2008-05-28 |
Encysive Pharmaceuticals Inc |
PYRIDINE, PYRIMIDINE, QUINOLINE, QUINAZOLINE AND NAPHTHALENE UROTENSIN II RECEPTOR ANTAGONISTS
|
|
AU2003219291A1
(en)
|
2003-03-24 |
2004-10-18 |
Vicore Pharma Ab |
Bicyclic compounds useful as angiotensin ii agonists
|
|
DE602004022819D1
(de)
|
2003-06-06 |
2009-10-08 |
Vertex Pharma |
Von atp-bindende kassette transportern
|
|
WO2005049593A2
(en)
|
2003-11-13 |
2005-06-02 |
Abbott Laboratories |
N-acylsulfonamide apoptosis promoters
|
|
CN101675928A
(zh)
|
2003-11-14 |
2010-03-24 |
沃泰克斯药物股份有限公司 |
可用作atp-结合弹夹转运蛋白调控剂的噻唑和噁唑
|
|
GB0328024D0
(en)
|
2003-12-03 |
2004-01-07 |
Glaxo Group Ltd |
Compounds
|
|
CA2554716A1
(en)
|
2004-01-22 |
2005-08-04 |
Nitromed, Inc. |
Nitrosated and/or nitrosylated compounds, compositions and methods of use
|
|
BRPI0507278A
(pt)
|
2004-01-30 |
2007-06-26 |
Vertex Pharma |
moduladores dos transportadores do cassete de ligação ao atp
|
|
US7977322B2
(en)
|
2004-08-20 |
2011-07-12 |
Vertex Pharmaceuticals Incorporated |
Modulators of ATP-binding cassette transporters
|
|
GEP20084360B
(en)
|
2004-02-04 |
2008-04-29 |
Pfizer Prod Inc |
Substituted quinoline compounds
|
|
TW200533336A
(en)
|
2004-03-02 |
2005-10-16 |
Fujisawa Pharmaceutical Co |
Concomitant drugs
|
|
CN101768129B
(zh)
|
2004-03-05 |
2012-05-23 |
日产化学工业株式会社 |
异*唑啉取代苯甲酰胺化合物的制备中间体
|
|
WO2005099705A2
(en)
|
2004-03-24 |
2005-10-27 |
Bayer Pharmaceuticals Corporation |
Preparation of imidazole derivatives and methods of use
|
|
EP1740532A4
(en)
|
2004-03-30 |
2009-06-10 |
Univ California |
CFTR INHIBITOR COMPOUNDS CONTAINING HYDRAZIDS AND USES THEREOF
|
|
GB0410121D0
(en)
|
2004-05-06 |
2004-06-09 |
Glaxo Group Ltd |
Compounds
|
|
RS56037B1
(sr)
|
2004-06-24 |
2017-09-29 |
Vertex Pharma |
Modulatori atp-vezujućih kasetnih transportera
|
|
US8354427B2
(en)
|
2004-06-24 |
2013-01-15 |
Vertex Pharmaceutical Incorporated |
Modulators of ATP-binding cassette transporters
|
|
CN101014572B
(zh)
|
2004-09-15 |
2011-07-06 |
盐野义制药株式会社 |
具有hiv整合酶抑制活性的氨基甲酰基吡啶酮衍生物
|
|
CN101031565B
(zh)
|
2004-09-29 |
2010-09-29 |
博尔托拉制药公司 |
取代的2h-1,3-苯并噁嗪-4(3h)-酮
|
|
EP1831170A4
(en)
|
2004-12-14 |
2009-10-14 |
Astrazeneca Ab |
SUBSTITUTED AMINOPYRIDINES AND THEIR USE
|
|
CA2591413A1
(en)
|
2004-12-16 |
2006-06-22 |
Vertex Pharmaceuticals Incorporated |
Pyrid-2-ones useful as inhibitors of tec family protein kinases for the treatment of inflammatory, proliferative and immunologically-mediated diseases
|
|
ES2321535T3
(es)
|
2004-12-23 |
2009-06-08 |
Glaxo Group Limited |
Compuestos de piridina para el tratamiento de enfermedades mediadas por prostaglandinas.
|
|
GB0428173D0
(en)
|
2004-12-23 |
2005-01-26 |
Astrazeneca Ab |
Compounds
|
|
JP5426878B2
(ja)
|
2005-05-24 |
2014-02-26 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Ａｔｐ−結合カセットトランスポーターのモジュレーター
|
|
WO2007019397A2
(en)
|
2005-08-05 |
2007-02-15 |
Genelabs Technologies, Inc. |
6-membered aryl and heteroaryl derivatives for the treatment of hepatitis c virus
|
|
US7999113B2
(en)
|
2005-08-11 |
2011-08-16 |
Vertex Pharmaceuticals Incorporated |
Modulators of cystic fibrosis transmembrane conductance regulator
|
|
WO2007053641A2
(en)
|
2005-11-01 |
2007-05-10 |
Mars, Incorporated |
A-type procyanidins and inflammation
|
|
CN102775396B
(zh)
|
2005-11-08 |
2014-10-08 |
沃泰克斯药物股份有限公司 |
Atp-结合弹夹转运蛋白的杂环调控剂
|
|
AU2006331565A1
(en)
|
2005-12-27 |
2007-07-05 |
Vertex Pharmaceuticals Incorporated |
Compounds useful in CFTR assays and methods therewith
|
|
EP3219705B1
(en)
|
2005-12-28 |
2020-03-11 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical compositions of the amorphous form of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
|
|
US7671221B2
(en)
|
2005-12-28 |
2010-03-02 |
Vertex Pharmaceuticals Incorporated |
Modulators of ATP-Binding Cassette transporters
|
|
CA2856037C
(en)
|
2005-12-28 |
2017-03-07 |
Vertex Pharmaceuticals Incorporated |
Modulators of atp-binding cassette transporters
|
|
US7932283B2
(en)
|
2006-04-05 |
2011-04-26 |
Bayer Cropscience Ag |
Fungicide N-cyclopropyl-sulfonylamide derivatives
|
|
EP2674428B1
(en)
|
2006-04-07 |
2016-04-06 |
Vertex Pharmaceuticals Incorporated |
Modulators of ATP-binding cassette transporters
|
|
CN101478964B
(zh)
|
2006-05-12 |
2012-02-29 |
沃泰克斯药物股份有限公司 |
N-[2,4-双(1,1-二甲基乙基)-5-羟苯基]-1,4-二氢-4-氧代喹啉-3-羧酰胺的组合物
|
|
US8778977B2
(en)
|
2006-06-30 |
2014-07-15 |
Sunesis Pharmaceuticals, Inc. |
Pyridinonyl PDK1 inhibitors
|
|
NZ576642A
(en)
|
2006-11-03 |
2011-11-25 |
Vertex Pharma |
Azaindole derivatives as cftr modulators
|
|
US7754739B2
(en)
|
2007-05-09 |
2010-07-13 |
Vertex Pharmaceuticals Incorporated |
Modulators of CFTR
|
|
CN101687789A
(zh)
|
2007-02-12 |
2010-03-31 |
因特蒙公司 |
C型肝炎病毒复制的新颖抑制剂
|
|
WO2008141385A1
(en)
|
2007-05-21 |
2008-11-27 |
Biota Scientific Management Pty Ltd |
Viral polymerase inhibitors
|
|
US8058299B2
(en)
|
2007-05-22 |
2011-11-15 |
Via Pharmaceuticals, Inc. |
Diacylglycerol acyltransferase inhibitors
|
|
CA2687608C
(en)
|
2007-05-25 |
2013-07-02 |
Amgen Inc. |
Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use
|
|
GB0716532D0
(en)
|
2007-08-24 |
2007-10-03 |
Angeletti P Ist Richerche Bio |
Therapeutic compounds
|
|
WO2009032116A1
(en)
|
2007-08-29 |
2009-03-12 |
Schering Corporation |
2, 3-substituted indole derivatives for treating viral infections
|
|
NZ620027A
(en)
|
2007-09-14 |
2015-05-29 |
Vertex Pharma |
Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
|
|
AU2013231151B2
(en)
|
2007-11-16 |
2015-06-25 |
Vertex Pharmaceuticals Incorporated |
Isoquinoline modulators of ATP-Binding Cassette transporters
|
|
MX2010005356A
(es)
|
2007-11-16 |
2010-05-27 |
Schering Corp |
Derivados de indol 3-heterociclico sustituidos y metodos de uso de los mismos.
|
|
GB0723794D0
(en)
|
2007-12-05 |
2008-01-16 |
Lectus Therapeutics Ltd |
Potassium ion channel modulators and uses thereof
|
|
EP3683218B1
(en)
|
2007-12-07 |
2024-09-18 |
Vertex Pharmaceuticals Incorporated |
Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid
|
|
MX365732B
(es)
|
2007-12-07 |
2019-06-12 |
Vertex Pharma |
Procesos para producir acidos cicloalquilcarboxamido-piridin benzoicos.
|
|
AU2013270464B2
(en)
|
2008-03-31 |
2016-05-26 |
Vertex Pharmaceuticals Incorporated |
Pyridyl derivatives as CFTR modulators
|
|
US20110071197A1
(en)
|
2008-04-16 |
2011-03-24 |
Peter Nilsson |
Bis-aryl compounds for use as medicaments
|
|
US20110112193A1
(en)
|
2008-05-14 |
2011-05-12 |
Peter Nilsson |
Bis-aryl compounds for use as medicaments
|
|
EP2145537A1
(en)
|
2008-07-09 |
2010-01-20 |
Bayer CropScience AG |
Plant growth regulator
|
|
UY31982A
(es)
|
2008-07-16 |
2010-02-26 |
Boehringer Ingelheim Int |
Derivados de 1,2-dihidropiridin-3-carboxamidas n-sustituidas
|
|
US20100074949A1
(en)
|
2008-08-13 |
2010-03-25 |
William Rowe |
Pharmaceutical composition and administration thereof
|
|
MX2011001782A
(es)
|
2008-08-13 |
2012-02-08 |
Vertex Pharma |
Composicion farmaceutica y su administracion.
|
|
EP2326178A4
(en)
|
2008-08-21 |
2012-10-24 |
Glaxosmithkline Llc |
INHIBITORS OF PROLYL-HYDROXYLASE
|
|
US7906553B2
(en)
|
2008-08-27 |
2011-03-15 |
Calcimedica, Inc. |
Substituted thiophene modulators of intracellular calcium
|
|
AR073709A1
(es)
|
2008-09-29 |
2010-11-24 |
Vertex Pharma |
Unidades de dosis de acido 3-(6-(1-(2,2-difluorobenzeno (d) (1,3) dioxol-5-il) ciclopropancarboxamido)-3-metilpiridin-2-il) benzoico
|
|
EP2349263B1
(en)
|
2008-10-23 |
2014-04-23 |
Vertex Pharmaceuticals Inc. |
Modulators of cystic fibrosis transmembrane conductance regulator
|
|
EP2940016A1
(en)
|
2008-11-06 |
2015-11-04 |
Vertex Pharmaceuticals Incorporated |
Modulators of ATP-binding cassette transporters
|
|
UA104876C2
(uk)
*
|
2008-11-06 |
2014-03-25 |
Вертекс Фармасьютікалз Інкорпорейтед |
Модулятори atф-зв'язувальних касетних транспортерів
|
|
UA108193C2
(uk)
|
2008-12-04 |
2015-04-10 |
|
Апоптозіндукуючий засіб для лікування раку і імунних і аутоімунних захворювань
|
|
US20100160322A1
(en)
|
2008-12-04 |
2010-06-24 |
Abbott Laboratories |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
|
|
EP2382197B1
(en)
|
2008-12-30 |
2016-10-05 |
Vertex Pharmaceuticals Incorporated |
Modulators of cystic fibrosis transmembrane conductance regulator
|
|
CN102282129A
(zh)
|
2009-01-19 |
2011-12-14 |
雅培制药有限公司 |
用于治疗癌症和免疫和自身免疫疾病的细胞程序死亡诱导药剂
|
|
CN102348684B
(zh)
|
2009-03-11 |
2014-11-12 |
拜尔农作物科学股份公司 |
被卤代烷基亚甲基氧基苯基取代的酮烯醇
|
|
PL2408750T3
(pl)
|
2009-03-20 |
2016-02-29 |
Vertex Pharma |
Sposób otrzymywania modulatorów błonowego regulatora przewodnictwa swoistego dla mukowiscydozy
|
|
HRP20181261T1
(hr)
|
2009-03-20 |
2018-12-14 |
Vertex Pharmaceuticals Incorporated |
Modulatori regulatora transmembranske provodljivosti cistične fibroze
|
|
US8835461B2
(en)
|
2009-03-26 |
2014-09-16 |
Shionogi & Co., Ltd. |
Substituted 3-hydroxy-4-pyridone derivative
|
|
EP2421368A4
(en)
|
2009-04-20 |
2013-01-09 |
Inst Oneworld Health |
COMPOUNDS, COMPOSITIONS AND METHODS FOR PYRIDAZINE SULFONAMIDE DERIVATIVES
|
|
NZ595708A
(en)
|
2009-05-26 |
2014-03-28 |
Abbvie Bahamas Ltd |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
|
|
WO2011102514A1
(ja)
|
2010-02-22 |
2011-08-25 |
武田薬品工業株式会社 |
芳香環化合物
|
|
US8247436B2
(en)
|
2010-03-19 |
2012-08-21 |
Novartis Ag |
Pyridine and pyrazine derivative for the treatment of CF
|
|
EP3037415A1
(en)
|
2010-03-19 |
2016-06-29 |
Vertex Pharmaceuticals Inc. |
Solid form of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
|
|
SI2826776T1
(sl)
|
2010-03-25 |
2021-02-26 |
Vertex Pharmaceuticals Incorporated |
Trdna disperzija amorfne oblike (R)-1(2,2-difluorobenzo(D)(1,3)dioksol-5-il)-N-(1-(2,3-dihidroksipropil) -6-fluoro-2-(1-hidroksi-2-metilpropan-2-il)-1H-indol-5-il)- ciklopropankarboksamida
|
|
MX2012011655A
(es)
|
2010-04-07 |
2012-11-23 |
Vertex Pharma |
Formas solidas de acido 3-(6-(1-(2,2-difluorobenzo [d][1-3]dioxol-5-il]ciclopropanocarboxamido)-3-metilpiridin-2-il) benzoico.
|
|
JP2013523833A
(ja)
|
2010-04-07 |
2013-06-17 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
３−（６−（１−（２，２−ジフルオロベンゾ［ｄ］［１，３］ジオキソール−５−イル）シクロプロパンカルボキサミド）−３−メチルピリジン−２−イル）安息香酸の医薬組成物およびその投与
|
|
US8344137B2
(en)
|
2010-04-14 |
2013-01-01 |
Hoffman-La Roche Inc. |
3,3-dimethyl tetrahydroquinoline derivatives
|
|
MX353408B
(es)
|
2010-04-22 |
2018-01-11 |
Vertex Pharma |
Proceso para producir compuestos de cicloalquilcarboxamido-indol.
|
|
EP2560649A1
(en)
|
2010-04-22 |
2013-02-27 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical compositions and administrations thereof
|
|
TWI520960B
(zh)
|
2010-05-26 |
2016-02-11 |
艾伯維有限公司 |
用於治療癌症及免疫及自體免疫疾病之細胞凋亡誘導劑
|
|
US8563593B2
(en)
|
2010-06-08 |
2013-10-22 |
Vertex Pharmaceuticals Incorporated |
Formulations of (R)-1-(2,2-difluorobenzo[D] [1,3] dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide
|
|
WO2012027247A2
(en)
|
2010-08-23 |
2012-03-01 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical composition of (r)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxy propyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl) cyclopropanecarboxamide and administration therof
|
|
CA2809263A1
(en)
|
2010-08-27 |
2012-03-01 |
Eleni Dokou |
Pharmaceutical composition and administrations thereof
|
|
US9394290B2
(en)
|
2010-10-21 |
2016-07-19 |
Universitaet Des Saarlandes Campus Saarbruecken |
Selective CYP11B1 inhibitors for the treatment of cortisol dependent diseases
|
|
WO2012087938A1
(en)
|
2010-12-20 |
2012-06-28 |
Glaxosmithkline Llc |
Quinazolinone derivatives as antiviral agents
|
|
EP2471363A1
(de)
|
2010-12-30 |
2012-07-04 |
Bayer CropScience AG |
Verwendung von Aryl-, Heteroaryl- und Benzylsulfonamidocarbonsäuren, -carbonsäureestern, -carbonsäureamiden und -carbonitrilen oder deren Salze zur Steigerung der Stresstoleranz in Pflanzen
|
|
CA2825746A1
(en)
|
2011-01-26 |
2012-08-02 |
Kyorin Pharmaceutical Co. Ltd. |
Pyrazolopyridine derivative or pharmacologically acceptable salt thereof
|
|
BR112013021021A2
(pt)
|
2011-02-17 |
2016-08-02 |
Bayer Ip Gmbh |
3- (bifenil - 3 - il) - 8, 8 - difluoro - 4 - hidroxi - 1 - azaspiro [4, 5] dec - 3 - eno - 2 - onas substituídas para terapia e cetoenóis espirocíclicos substituídos com halogéneo
|
|
KR101789527B1
(ko)
|
2011-03-01 |
2017-10-25 |
바이엘 인텔렉쳐 프로퍼티 게엠베하 |
2-아실옥시피롤린-4-온
|
|
AR085585A1
(es)
|
2011-04-15 |
2013-10-09 |
Bayer Cropscience Ag |
Vinil- y alquinilciclohexanoles sustituidos como principios activos contra estres abiotico de plantas
|
|
RS56096B1
(sr)
|
2011-05-18 |
2017-10-31 |
Concert Pharmaceuticals Inc |
Deuterisani derivati ivakaftora
|
|
HUE047354T2
(hu)
|
2011-05-18 |
2020-04-28 |
Vertex Pharmaceuticals Europe Ltd |
Ivacaftor deuterizált származékai
|
|
US9260416B2
(en)
|
2011-05-27 |
2016-02-16 |
Amira Pharmaceuticals, Inc. |
Heterocyclic autotaxin inhibitors and uses thereof
|
|
MX2014002459A
(es)
|
2011-08-30 |
2014-04-10 |
Chdi Foundation Inc |
Inhibidores de quinurenina-3-monooxigenasa, composiciones farmaceuticas y metodos de uso de los mismos.
|
|
CN103946221B
(zh)
|
2011-09-16 |
2016-08-03 |
诺华股份有限公司 |
用于治疗囊性纤维化的杂环化合物
|
|
CN103929956B
(zh)
|
2011-09-16 |
2017-02-22 |
拜耳知识产权有限责任公司 |
酰基磺酰胺用于改善植物产量的用途
|
|
WO2013038373A1
(en)
|
2011-09-16 |
2013-03-21 |
Novartis Ag |
Pyridine amide derivatives
|
|
BR112014006940A2
(pt)
|
2011-09-23 |
2017-04-04 |
Bayer Ip Gmbh |
uso de derivados de ácido 1-fenilpirazol-3-carboxílico 4-substituído como agentes contra estresse abiótico em plantas
|
|
WO2013070961A1
(en)
|
2011-11-08 |
2013-05-16 |
Vertex Pharmaceuticals Incorporated |
Modulators of atp-binding cassette transporters
|
|
US8426450B1
(en)
|
2011-11-29 |
2013-04-23 |
Helsinn Healthcare Sa |
Substituted 4-phenyl pyridines having anti-emetic effect
|
|
NZ727015A
(en)
|
2012-01-25 |
2017-12-22 |
Vertex Pharma |
Formulations of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
|
|
JP2015083542A
(ja)
|
2012-02-08 |
2015-04-30 |
大日本住友製薬株式会社 |
３位置換プロリン誘導体
|
|
JP2015511583A
(ja)
|
2012-02-27 |
2015-04-20 |
バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ |
薬学的組成物およびその投与
|
|
US8889730B2
(en)
|
2012-04-10 |
2014-11-18 |
Pfizer Inc. |
Indole and indazole compounds that activate AMPK
|
|
WO2013158121A1
(en)
|
2012-04-20 |
2013-10-24 |
Vertex Pharmaceuticals Incorporated |
Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
|
|
CN104718188B
(zh)
|
2012-05-22 |
2018-08-21 |
基因泰克公司 |
N-取代的苯甲酰胺类及其在治疗疼痛中的用途
|
|
AU2013270681A1
(en)
|
2012-06-08 |
2014-12-18 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical compositions for the treatment of CFTR -mediated disorders
|
|
WO2013185202A1
(en)
|
2012-06-14 |
2013-12-19 |
Beta Pharma Canada Inc |
Apoptosis inducers
|
|
KR101663436B1
(ko)
|
2012-07-06 |
2016-10-06 |
제넨테크, 인크. |
N-치환된 벤즈아미드 및 이의 사용 방법
|
|
AR092857A1
(es)
|
2012-07-16 |
2015-05-06 |
Vertex Pharma |
Composiciones farmaceuticas de (r)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-il)-n-(1-(2,3-dihidroxipropil)-6-fluoro-2-(1-hidroxi-2-metilpropan-2-il)-1h-indol-5-il)ciclopropancarboxamida y administracion de las mismas
|
|
JP2015178458A
(ja)
|
2012-07-25 |
2015-10-08 |
杏林製薬株式会社 |
ベンゼン環縮合含窒素５員複素環式化合物、またはその薬理学的に許容される塩
|
|
CN103571906B
(zh)
|
2012-07-27 |
2018-12-11 |
上海泽元海洋生物技术有限公司 |
一种利用微藻高效生产虾青素的新方法
|
|
WO2014028381A1
(en)
|
2012-08-13 |
2014-02-20 |
Abbvie Inc. |
Apoptosis-inducing agents
|
|
US9896443B2
(en)
|
2012-08-21 |
2018-02-20 |
Peter Maccallum Cancer Institute |
Perforin inhibiting benzenesulfonamide compounds, preparation and uses thereof
|
|
MX2015002887A
(es)
|
2012-09-06 |
2015-07-06 |
Plexxikon Inc |
Compuestos y metodos para la modulacion de cinasas, e indicaciones para ello.
|
|
US10093640B2
(en)
|
2012-09-21 |
2018-10-09 |
Vanderbilt University |
Substituted benzofuran, benzothiophene and indole MCL-1 inhibitors
|
|
US9567301B2
(en)
|
2012-11-02 |
2017-02-14 |
Dana-Farber Cancer Institute, Inc. |
Pyrrol-1-yl benzoic acid derivatives useful as myc inhibitors
|
|
EP2914248B2
(en)
|
2012-11-02 |
2023-10-18 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical compositions for the treatment of cftr mediated diseases
|
|
US9458137B2
(en)
|
2012-11-05 |
2016-10-04 |
Nantbioscience, Inc. |
Substituted indol-5-ol derivatives and their therapeutical applications
|
|
MY183582A
(en)
|
2012-11-19 |
2021-02-26 |
Vertex Pharmaceuticals Europe Ltd |
Deuterated cftr potentiators
|
|
WO2014086751A1
(de)
|
2012-12-05 |
2014-06-12 |
Bayer Cropscience Ag |
Verwendung substituierter 1-(arylethinyl)-, 1-(heteroarylethinyl)-, 1-(heterocyclylethinyl)- und 1-(cyloalkenylethinyl)-cyclohexanole als wirkstoffe gegen abiotischen pflanzenstress
|
|
JP2016504300A
(ja)
|
2012-12-05 |
2016-02-12 |
バイエル・クロップサイエンス・アクチェンゲゼルシャフト |
置換された１−（アリールエチニル）−、１−（ヘテロアリールエチニル）−、１−（複素環エチニル）−および１−（シクロアルケニルエチニル）ビシクロアルカノールの非生物的植物ストレスに対する活性薬剤としての使用
|
|
UA115576C2
(uk)
|
2012-12-06 |
2017-11-27 |
Байєр Фарма Акцієнгезелльшафт |
Похідні бензимідазолу як антагоністи ер4
|
|
GB201223265D0
(en)
|
2012-12-21 |
2013-02-06 |
Selvita Sa |
Novel benzimidazole derivatives as kinase inhibitors
|
|
US20150353542A1
(en)
|
2013-01-14 |
2015-12-10 |
Amgen Inc. |
Methods of using cell-cycle inhibitors to modulate one or more properties of a cell culture
|
|
US9637450B2
(en)
|
2013-03-14 |
2017-05-02 |
The Trustees Of Columbia University In The City Of New York |
Octahydrocyclopentapyrroles, their preparation and use
|
|
EP2968304B1
(en)
|
2013-03-14 |
2018-10-10 |
The Trustees of Columbia University in the City of New York |
4-phenylpiperidines, their preparation and use
|
|
SI2970243T1
(sl)
|
2013-03-15 |
2020-04-30 |
Cyclerion Therapeutics, Inc. |
SGC stimulatorji
|
|
PT2978752T
(pt)
|
2013-03-29 |
2018-03-09 |
Takeda Pharmaceuticals Co |
Derivados de 6-(5-hidroxi-1h-pirazol-1-il)nicotinamida e o seu uso como inibidores de phd
|
|
WO2014180562A1
(en)
|
2013-05-07 |
2014-11-13 |
Galapagos Nv |
Novel compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis
|
|
WO2014181287A1
(en)
|
2013-05-09 |
2014-11-13 |
Piramal Enterprises Limited |
Heterocyclyl compounds and uses thereof
|
|
EP3000073B1
(en)
|
2013-05-21 |
2017-07-12 |
Sicpa Holding SA |
Identifying one- or two-dimensional bar codes via weighted image data combination
|
|
AU2014268477A1
(en)
|
2013-05-24 |
2015-11-12 |
The California Institute For Biomedical Research |
Compounds for treatment of drug resistant and persistent tuberculosis
|
|
WO2015010832A1
(en)
|
2013-07-22 |
2015-01-29 |
Syngenta Participations Ag |
Microbiocidal heterocyclic derivatives
|
|
US10005728B2
(en)
|
2013-08-28 |
2018-06-26 |
Vanderbilt University |
Substituted indole Mcl-1 inhibitors
|
|
WO2015051043A1
(en)
|
2013-10-01 |
2015-04-09 |
Amgen Inc. |
Biaryl acyl-sulfonamide compounds as sodium channel inhibitors
|
|
WO2015069287A1
(en)
|
2013-11-08 |
2015-05-14 |
Allergan, Inc. |
Compounds as tyrosine kinase modulators
|
|
AU2014349010C1
(en)
|
2013-11-12 |
2020-08-06 |
Vertex Pharmaceuticals Incorporated |
Process of preparing pharmaceutical compositions for the treatment of CFTR mediated diseases
|
|
RU2744460C2
(ru)
|
2014-04-15 |
2021-03-09 |
Вертекс Фармасьютикалз Инкорпорейтед |
Фармацевтические композиции для лечения заболеваний, опосредованных муковисцидозным трансмембранным регулятором проводимости
|
|
MA41051B1
(fr)
|
2014-10-06 |
2020-11-30 |
Vertex Pharma |
Modulateurs du régulateur de conductance transmembranaire de la mucoviscidose
|
|
CN107250113B
(zh)
|
2014-10-07 |
2019-03-29 |
弗特克斯药品有限公司 |
囊性纤维化跨膜传导调节蛋白的调节剂的共晶
|
|
RU2691136C2
(ru)
|
2014-11-18 |
2019-06-11 |
Вертекс Фармасьютикалз Инкорпорейтед |
Способ проведения высокопроизводительной тестовой высокоэффективной жидкостной хроматографии
|
|
US10738011B2
(en)
|
2014-12-23 |
2020-08-11 |
Proteostasis Therapeutics, Inc. |
Derivatives of 5-(hetero)arylpyrazol-3-carboxylic amide or 1-(hetero)aryltriazol-4-carboxylic amide useful for the treatment of inter alia cystic fibrosis
|
|
MA41253A
(fr)
|
2014-12-23 |
2017-10-31 |
Proteostasis Therapeutics Inc |
Composés, compositions et procédés pour augmenter l'activité du cftr
|
|
SG11201706451TA
(en)
|
2015-02-15 |
2017-09-28 |
Hoffmann La Roche |
1-(het)arylsulfonyl-(pyrrolidine or piperidine)-2-carboxamide derivatives and their use as trpa1 antagonists
|
|
EP3277647A1
(en)
|
2015-03-31 |
2018-02-07 |
Vertex Pharmaceuticals (Europe) Limited |
Deuterated vx-661
|
|
KR102828163B1
(ko)
|
2015-09-21 |
2025-07-02 |
버텍스 파마슈티칼스 (유럽) 리미티드 |
중수소화된 cftr 강화제의 투여
|
|
EP3352758A2
(en)
|
2015-09-25 |
2018-08-01 |
Vertex Pharmaceuticals (Europe) Limited |
Deuterated cftr potentiators
|
|
EP3436432B1
(en)
|
2016-03-30 |
2021-01-27 |
Genentech, Inc. |
Substituted benzamides and methods of use thereof
|
|
CA3019380A1
(en)
|
2016-03-31 |
2017-10-05 |
Vertex Pharmaceuticals Incorporated |
Modulators of cystic fibrosis transmembrane conductance regulator
|
|
MA43775A
(fr)
|
2016-04-07 |
2021-05-05 |
Proteostasis Therapeutics Inc |
Analogues du ivacaftor conentant des atomes de silicium
|
|
AU2017256172A1
(en)
|
2016-04-26 |
2018-09-06 |
AbbVie S.à.r.l. |
Modulators of cystic fibrosis transmembrane conductance regulator protein
|
|
US10138227B2
(en)
|
2016-06-03 |
2018-11-27 |
Abbvie S.Á.R.L. |
Heteroaryl substituted pyridines and methods of use
|
|
MA45397A
(fr)
|
2016-06-21 |
2019-04-24 |
Proteostasis Therapeutics Inc |
Composés, compositions et procédés pour augmenter l'activité du cftr
|
|
CN109803962B
(zh)
|
2016-09-30 |
2022-04-29 |
弗特克斯药品有限公司 |
囊性纤维化跨膜传导调控蛋白的调节剂、以及药物组合物
|
|
US9981910B2
(en)
|
2016-10-07 |
2018-05-29 |
Abbvie S.Á.R.L. |
Substituted pyrrolidines and methods of use
|
|
US10399940B2
(en)
|
2016-10-07 |
2019-09-03 |
Abbvie S.Á.R.L. |
Substituted pyrrolidines and methods of use
|
|
AU2017348186A1
(en)
|
2016-10-26 |
2019-05-16 |
Proteostasis Therapeutics, Inc |
Pyridazine derivatives, compositions and methods for modulating CFTR
|
|
CA3041675A1
(en)
|
2016-10-26 |
2018-05-03 |
Proteostasis Therapeutics, Inc. |
N-phenyl-2-(3-phenyl-6-oxo-1,6-dihydropyridazin-1-yl)acetamide derivatives for treating cystic fibrosis
|
|
WO2018081378A1
(en)
|
2016-10-26 |
2018-05-03 |
Proteostasis Therapeutics, Inc. |
Compounds, compositions, and methods for modulating cftr
|
|
AU2017352206B2
(en)
|
2016-10-27 |
2022-03-03 |
Vertex Pharmaceuticals (Europe) Limited |
Methods of treatment with deuterated CFTR potentiators
|
|
MX387203B
(es)
|
2016-11-18 |
2025-03-18 |
Cystic Fibrosis Found |
Pirrolopirimidinas como potenciadores de cftr.
|
|
MD3551622T2
(ro)
*
|
2016-12-09 |
2021-03-31 |
Vertex Pharma |
Modulator al regulatorului conductanței transmembranare în fibroză chistică, compoziții farmaceutice, metode de tratament și procedeu pentru fabricarea modulatorului
|
|
SG10201911076QA
(en)
|
2016-12-16 |
2020-01-30 |
Cystic Fibrosis Found |
Bycyclic heteroaryl derivatives as cftr potentiators
|
|
EP3558982A1
(en)
|
2016-12-20 |
2019-10-30 |
AbbVie S.À.R.L. |
Deuterated cftr modulators and methods of use
|
|
EP3565815B1
(en)
|
2017-01-07 |
2024-03-13 |
Fochon Pharmaceuticals, Ltd. |
Compounds as bcl-2-selective apoptosis-inducing agents
|
|
TW201831471A
(zh)
|
2017-02-24 |
2018-09-01 |
盧森堡商艾伯維公司 |
囊腫纖化症跨膜傳導調節蛋白的調節劑及其使用方法
|
|
WO2018183367A1
(en)
|
2017-03-28 |
2018-10-04 |
Van Goor Fredrick F |
Methods of treating cystic fibrosis in patients with residual function mutations
|
|
MA49061A
(fr)
|
2017-04-28 |
2021-04-21 |
Proteostasis Therapeutics Inc |
Dérivés 4-sulfonylaminocarbonylquinoline pour augmenter l'activité cftr
|
|
US11253509B2
(en)
|
2017-06-08 |
2022-02-22 |
Vertex Pharmaceuticals Incorporated |
Methods of treatment for cystic fibrosis
|
|
US20210069174A1
(en)
|
2017-07-01 |
2021-03-11 |
Vertex Pharmaceuticals Incorporated |
Compositions and methods for treatment of cystic fibrosis
|
|
US20200171015A1
(en)
|
2017-07-17 |
2020-06-04 |
Vertex Pharmaceuticals Incorporated |
Methods of treatment for cystic fibrosis
|
|
MA49631A
(fr)
|
2017-07-17 |
2020-05-27 |
Vertex Pharma |
Méthodes de traitement de la fibrose kystique
|
|
WO2019026075A1
(en)
|
2017-07-31 |
2019-02-07 |
Technion Research & Development Foundation Limited |
METHODS OF DETECTING MODIFIED AND UN-MODIFIED DNA
|
|
JP7121794B2
(ja)
|
2017-08-02 |
2022-08-18 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
ピロリジン化合物を調製するためのプロセス
|
|
US10988454B2
(en)
|
2017-09-14 |
2021-04-27 |
Abbvie Overseas S.À.R.L. |
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
|
|
AU2018346602B2
(en)
|
2017-10-06 |
2024-10-17 |
Proteostasis Therapeutics, Inc. |
Compounds, compositions and methods for increasing CFTR activity
|
|
WO2019079760A1
(en)
|
2017-10-19 |
2019-04-25 |
Vertex Pharmaceuticals Incorporated |
CRYSTALLINE FORMS AND COMPOSITIONS OF CFTR MODULATORS
|
|
MA51206A
(fr)
|
2017-12-01 |
2020-10-07 |
Vertex Pharma |
Procédés pour préparer des modulateurs de régulateur de conductance transmembranaire de mucoviscidose
|
|
WO2019113089A1
(en)
|
2017-12-04 |
2019-06-13 |
Vertex Pharmaceuticals Incorporated |
Compositions for treating cystic fibrosis
|
|
EP3720849A2
(en)
|
2017-12-08 |
2020-10-14 |
Vertex Pharmaceuticals Incorporated |
Processes for making modulators of cystic fibrosis transmembrane conductance regulator
|
|
TWI810243B
(zh)
|
2018-02-05 |
2023-08-01 |
美商維泰克斯製藥公司 |
用於治療囊腫纖化症之醫藥組合物
|
|
US20210009560A1
(en)
|
2018-03-30 |
2021-01-14 |
Vertex Pharmaceuticals Incorporated |
Crystalline forms of modulators of cftr
|
|
WO2019195739A1
(en)
|
2018-04-05 |
2019-10-10 |
Alexander Russell Abela |
Modulators of cystic fibrosis transmembrane conductance regulator
|
|
EP3774825A1
(en)
|
2018-04-13 |
2021-02-17 |
Vertex Pharmaceuticals Incorporated |
Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
|
|
WO2020214921A1
(en)
|
2019-04-17 |
2020-10-22 |
Vertex Pharmaceuticals Incorporated |
Solid forms of modulators of cftr
|
|
WO2020242935A1
(en)
|
2019-05-29 |
2020-12-03 |
Vertex Pharmaceuticals Incorporated |
Methods of treatment for cystic fibrosis
|
|
WO2021030552A1
(en)
|
2019-08-14 |
2021-02-18 |
Vertex Pharmaceuticals Incorporated |
Crystalline forms of cftr modulators
|
|
TWI867024B
(zh)
|
2019-08-14 |
2024-12-21 |
美商維泰克斯製藥公司 |
囊腫纖維化跨膜傳導調節蛋白之調節劑
|
|
TWI899097B
(zh)
|
2019-08-14 |
2025-10-01 |
美商維泰克斯製藥公司 |
製備cftr調節劑之方法
|
|
US20220313698A1
(en)
|
2019-08-14 |
2022-10-06 |
Vertex Pharmaceuticals Incorporated |
Modulators of cystic fibrosis transmembrane conductance regulator
|